Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

3.160 USD -0.235 (-6.92%)
Official Closing Price Updated: 7:50 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agenus Inc

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Biotechs Seek Advancements In The Immuno-Oncology Field For Childhood Brain Tumors
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs Seek Advancements in the Immuno-Oncology Field for Childhood Brain Tumors
Financialnewsmedia.com News Commentary 
From PR Newswire
The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags KDMN TELA OCGN
From Benzinga
UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers
UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of uro-oncology, today announced that it has entered into an... 
From Business Wire News Releases
Agenus receives $10M from UroGen Pharma for rights to Zalifrelimab (CTLA-4) for intravesical treatment of urinary tract cancers
- UroGen receives rights to zalifrelimab to be used in its proprietary sustained release formulation for patients with high-grade non-muscle invasive bladder cancer 
From PR Newswire
The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags XOMA PLXP HSDT
From Benzinga
Are These Penny Stocks a Buy Or Sell?
3 Penny Stocks to Watch in November When it comes to penny… 
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Global Nanotechnology And Nanomedicine Treatment Markets Could Reach $350 Billion By 2025
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Nanotechnology and Nanomedicine Treatment Markets Could Reach $350 Billion by 2025
Financialnewsmedia.com News Commentary 
From PR Newswire
Noteworthy Wednesday Option Activity: AGEN, ECOL, SONO
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Agenus Inc (AGEN), where a total of 12,720 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Analysts Anticipate 21% Upside For IEIH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Agenus Inc (AGEN) Q3 2019 Earnings Call Transcript
AGEN earnings call for the period ending September 30, 2019. 
Tags Market News AGEN
From Motley Fool
Agenus Provides Corporate Update with Third Quarter 2019 Financial Results
- PD-1 plus CTLA-4 cervical trial completes planned accrual & planned interim analysis 
From PR Newswire
Agenus to Report Third Quarter 2019 Financial Results on November 4, 2019 and Host Conference Call and Webcast
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, will release its third quarter 2019 financial results before the market opens... 
From PR Newswire
3 Cancer Treatment Stocks to Buy Right Now
These three beaten-down cancer stocks could prove to be amazing value plays. 
Tags PBYI AGEN Market News
From Motley Fool
Patients Turn to Assistance Programs for Aid in the Fight Against Chronic Diseases
FinancialBuzz.com News Commentary 
From PR Newswire
IEIH's Holdings Could Mean 28% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biotechs Endeavour to Increase Access to Cancer Treatments
FinancialBuzz.com News Commentary 
From PR Newswire
Agenus to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, announced today that Jennifer Buell, PhD,... 
From PR Newswire
VBI Vaccines Announces Phase 2a Clinical Evaluation of VBI-1901 Cancer Vaccine Candidate in Combination with GSK’s AS01B Adjuvant System in Recurrent Glioblastoma Patients
VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced a collaboration with... 
From Business Wire News Releases
The Implied Analyst 12-Month Target For IEIH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Commit To Purchase Agenus At $2, Earn 9.9% Annualized Using Options
Investors considering a purchase of Agenus Inc (AGEN) shares, but tentative about paying the going market price of $2.83/share, might benefit from considering selling puts among the alternative... 
Tags Stocks
From Market News Video
Agenus Inc (AGEN) Q2 2019 Earnings Call Transcript
AGEN earnings call for the period ending June 30, 2019. 
Tags AGEN Market News
From Motley Fool
110 Biggest Movers From Yesterday
Gainers Corindus Vascular Robotics, Inc. (NYSE: CVRS) climbed 76.5% to close at $4.27 on Thursday after the company agreed to be ... 
Tags VERI GTS NTRA
From Benzinga
90 Stocks Moving In Thursday's Mid-Day Session
Gainers Corindus Vascular Robotics, Inc. (NYSE: CVRS) surged 75.6% to $4.25 after the company agreed to be acquired by Siemens ... 
Tags FTDR VSTO Trading Ideas
From Benzinga
Agenus Reports Second Quarter 2019 Financial Results and Provides Corporate Update
- Enrollment of CTLA-4 & PD-1 trials on track; data expected 2H2019 
From PR Newswire
Agenus Milestone Triggers $7.5M Payment
- FDA acceptance of IND filing for AGEN2373 triggers payment and clears path to begin clinical trials 
From PR Newswire
Agenus to Report Second Quarter 2019 Financial Results on August 8, 2019 and Host Conference Call and Webcast
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, will release its second quarter 2019 financial results before the market... 
From PR Newswire
33 Healthcare Stocks Moving In Today's Pre-Market Session
Gainers Valeritas Holdings, Inc. (NASDAQ: VLRX) stock rose 15.2% today to $2.88 during Tuesday's pre-market session. The ... 
Tags THC Trading Ideas MOR
From Benzinga
Agenus Appoints Don Vidic as Vice President and Head of Commercial
The appointment comes as Agenus is preparing for its first BLA filing in 2020 and evolving towards a commercial company 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.